Sanofi | SNY - Current Liabilities




Sanofi reported 30.03B in Current Liabilities for its fiscal quarter ending in June of 2024.

Current Liabilities Change Date
AbbVie USD 43.06B 1.15B Sep/2024
Amgen USD 23.1B 2.79B Dec/2024
AstraZeneca USD 27.87B 1.94B Dec/2024
Bristol-Myers Squibb USD 23.77B 1.14B Dec/2024
Canopy Growth CAD 281.28M 114.68M Sep/2024
Corcept Therapeutics USD 126.22M 25.47M Sep/2024
Drreddys Laboratories INR 129.3B 23.63B Sep/2024
Eli Lilly USD 24.67B 2.45B Sep/2024
Galapagos EUR 335.08M 16.15M Dec/2024
Genmab DKK 5.31B 723M Dec/2024
GlaxoSmithKline GBP 21.7B 238M Dec/2024
Glaxosmithkline GBP 21.46B 1.11B Sep/2024
Indivior 962M 50M Sep/2024
J&J USD 51.76B 2.17B Sep/2024
Merck USD 29.59B 3.53B Sep/2024
Novartis USD 28.69B 560M Dec/2024
Novartis USD 28.13B 520M Sep/2024
Pacira USD 306.4M 213.71M Sep/2024
Perrigo USD 1.45B 37.6M Sep/2024
Pfizer USD 43.21B 608M Sep/2024
Prestige Brands USD 102.54M 4.36M Dec/2024
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 30.03B 5.82B Jun/2024
Sanofi 30.03B 5.82B Jun/2024
Supernus Pharmaceuticals USD 291.51M 17.15M Sep/2024
UCB EUR 2.8B 182M Jun/2024
Zoetis USD 3.41B 1.71B Dec/2024